A highly publicized new study of the antidepressant fluvoxamine as a potential COVID-19 treatment suggests that the drug could reduce hospitalizations among people with the disease, but has prompted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback